Rubicon Research IPO GMP, Price, Lot Size, & Allotment Details

Rubicon Research IPO – An Overview and Company Insight

Rubicon Research IPO GMP is drawing early attention from the investor community, especially in the pharma / specialty formulations space. Rubicon Research is a specialty pharmaceutical company that develops, manufactures, and markets differentiated formulations and drug-device combinations, particularly targeting regulated markets like the U.S. The company has R&D centers in India and Canada, and multiple manufacturing sites in India. They hold US FDA and WHO-GMP accreditations, giving them credibility in international markets.
The IPO is a mix of fresh issue + Offer For Sale (OFS). The fresh portion is aimed at reducing debt, supporting inorganic growth, and funding strategic investments. The OFS gives promoters / early investors a chance to exit partially. With performance improving in recent years, Rubicon is positioning itself as a growth story in Indian pharma.

Rubicon Research IPO – Grey Market Premium (GMP)

At this stage, a well-confirmed GMP for Rubicon Research hasn’t been firmly established. Market whispers suggest modest premiums depending on subscription interest. Because there’s a significant OFS portion, investor sentiment will likely be tempered. If demand is strong, a listing gain of 5-10% over the upper price band could be possible. Investors will be closely watching anchor allocations, subscription trends, and how the GMP evolves closer to listing.

Rubicon Research IPO GMP

Date	IPO GMP	GMP Trend	Gain
Today	₹80		16.49%
6 Oct	₹68		14.02%

Pricing Details and Lot Size – Rubicon Research IPO

• Price Band: ₹ 461 to ₹ 485 per share

• Face Value: Re. 1 / ₹ 1 per share

• Minimum Lot Size: 30 shares

• Minimum Retail Investment: 30 × ₹ 485 = ₹ 14,550

• Allocation Structure: Largely skewed towards institutional investors; retail portion is smaller (often ~ 10%)

• Fresh vs OFS: ~ ₹ 500 crore as fresh issue, ~ ₹ 585 crore as OFS

IPO Timelines at a Glance – Rubicon Research IPO

How To Check the Allotment Status

After the IPO closes and allotment is finalised (expected on 14 October 2025):

• Registrar’s Website: MUFG Intime India Pvt. Ltd will host an “IPO Allotment Status” section. Use your PAN / Application Number / Demat ID to check.

• NSE / BSE: Under “Corporate Actions / IPO Allotment Status,” choose Rubicon Research Ltd. and enter your credentials to view allotment result.

Book-running Lead Managers and Registrar

• Lead Managers: Axis Capital, IIFL Capital, JM Financial, SBI Capital Markets

• Registrar: MUFG Intime India Pvt. Ltd

Offer for Sale and IPO Size Breakdown

• Total Issue Size: ₹ 1,085 crore

• Fresh Issue: ~ ₹ 500 crore

• OFS: ~ ₹ 585 crore

• The OFS is being conducted by General Atlantic Singapore, a primary promoter / investor.

Utilisation of Fresh Funds and Strategic Initiatives

• A chunk of fresh funds (~ ₹ 310 crore) is intended for debt repayment and deleveraging

• Remaining fresh funds will support acquisitions, scaling R&D, regulatory & compliance infrastructure, and general corporate purposes

• Rubicon has already made strategic moves: it acquired a formulations facility in Pithampur for ₹ 149 crore to enhance manufacturing capability

IPO Financial Information

Rubicon has shown impressive financial turnaround:

• From losses / moderate profits in earlier years, it has moved to stronger revenue and margin growth

• In FY24 and FY25, it posted major expansions in revenue and profitability; margins have improved

• The strength lies in specialization, regulated market access, and product pipeline

Conclusion

Rubicon Research IPO is shaping up to be one of the more watched pharma offerings this year. Rubicon Research IPO GMP may climb if sentiment supports it. The company’s credentials in regulated markets, a robust pipeline, and improved financials make it an attractive pick for medium to long-term investors. That said, investors must weigh valuation stretch, regulatory risk, export exposure, and execution capability before subscribing.

Investing in IPOs Made Simple

Thinking of applying for the Rubicon Research IPO or similar upcoming offerings? The first step is to open a demat account if you don’t already have one, so you can participate smoothly in IPOs and track your holdings.
At TradeSmart, we make this easy: low brokerage, intuitive platform, reliable service and support—built to help investors execute IPOs and trades confidently. Subscribe early, apply for Rubicon or other IPOs, and let your investments grow seamlessly.

Disclaimer

This article is for informational purposes only and should not be construed as investment advice or a recommendation to subscribe to the Rubicon Research IPO. Investors are advised to read the Red Herring Prospectus (RHP) carefully and consult a certified financial advisor before making any investment decisions. IPO Grey Market Premium (GMP) values mentioned are indicative, based on market speculation, and may fluctuate. TradeSmart and its associates are not liable for any financial losses or decisions made based on this content.